Cobicistat (GS-9350)
目录号: A11277
CYP3A 抑制剂
Cobicistat 是一种强效的细胞色素P450 3A酶抑制剂,包括重要的 CYP3A4 亚型。它还抑制肠道转运蛋白,增加了包括阿塔那韦、达芦那韦和 替诺福韦 阿拉酚胺酯在内的几种HIV药物的整体吸收。
Discription | Cobicistat is a potent inhibitor of cytochrome P450 3A enzymes, including the important CYP3A4 subtype. It also inhibits intestinal transport proteins, increasing the overall absorption of several HIV medications, including atazanavir, darunavir and tenofovir alafenamide fumarate. | ||
---|---|---|---|
Targets |
|
目录号 | A11277 |
---|---|
分子式 | C40H53N7O5S2 |
分子量 | 766 |
CAS号 | 1004316-88-4 |
SMILES | CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5 |
其他名称 | GS9350 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 85 mg/mL (109.53 mM) | |
Water | Insoluble | ||
Ethanol | 85 mg/mL (109.53 mM) | ||
In vivo | 5% DMSO+40% PEG 300+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 13.05 mL | 65.27 mL | 130.55 mL |
0.5 mM | 2.61 mL | 13.05 mL | 26.11 mL |
1 mM | 1.31 mL | 6.53 mL | 13.05 mL |
5 mM | 0.26 mL | 1.31 mL | 2.61 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2